North America Disposable Endoscopes Market Size - Share Outlook, Growth Analysis Report and Forecast Trends 2026-2030

The North America disposable endoscopes market represents one of the faster-growing segments within the broader medical devices industry, as clinicians and infection-control teams move away from reusable endoscopes toward sterile, single-use alternatives. The market is valued at approximately $3.0 billion in 2025 and is projected to expand at roughly 12.9% annually through the end of the decade, supported by hospital procurement budgets and increasing procedure volumes. Demand is concentrated in the United States, with Canada representing a smaller but steadily developing secondary market.

• •North America disposable endoscopes market valued near $3.0 billion in 2025.
• •Forecast compound annual growth rate of approximately 12.9% through 2030.
• •United States accounts for the dominant share, with Canada as the secondary market.

Infection prevention has become a top operational priority for hospitals following high-profile outbreaks linked to reusable duodenoscopes and other complex endoscopes, pushing facilities to adopt single-use alternatives for high-risk procedures. Reimbursement policies and value-based care incentives further encourage capital-light procurement of disposable devices that eliminate costly reprocessing, repair, and downtime. An aging North American population is also lifting the volume of endoscopic procedures in gastroenterology, urology, ENT, and pulmonology.

• •Rising incidence of hospital-acquired infections tied to reusable scopes.
• •Aging population driving higher volumes of diagnostic and therapeutic endoscopic procedures.
• •Cost savings from eliminating reprocessing, repair, and sterilization workflows.

The market is typically segmented by product type, including flexible disposable endoscopes for GI applications, bronchoscopes, ureteroscopes, cystoscopes, rhinolaryngoscopes, and other specialty scopes, along with supporting visualization hardware and accessories. Application areas span gastrointestinal endoscopy, urology, ENT, pulmonology, and gynecology, while end users include hospitals, ambulatory surgical centers, and diagnostic clinics. Regionally, the United States dominates North American demand due to its larger procedure base and earlier regulatory clarity, while Canada is gradually expanding adoption as infection-control standards align.

• •Product segmentation spans flexible GI, urology, ENT, bronchoscopy, and gynecology scopes.
• •Hospitals are the leading end users, with ambulatory surgical centers growing fastest.
• •United States leads regional revenue, with Canada emerging as a secondary growth market.

What are the recent trends and outlook?

The near-term outlook points to continued double-digit growth as more hospitals standardize on single-use scopes for high-risk indications while keeping reusable systems for lower-acuity, high-volume cases. Technology trends include higher-resolution chip-on-tip imaging, improved maneuverability of flexible tips, AI-assisted lesion detection, and integration with hospital IT systems for documentation and reporting. Regulatory scrutiny around reusable device reprocessing is expected to remain a long-term tailwind, reinforcing the structural shift toward disposable platforms across North America.

• •Adoption is moving from selective use toward routine, hospital-wide procurement.
• •Innovation focuses on improved imaging, ergonomics, and AI-assisted diagnostics.
• •Tighter reprocessing oversight for reusable scopes is expected to sustain double-digit growth.